-
公开(公告)号:US20110312964A1
公开(公告)日:2011-12-22
申请号:US13139962
申请日:2009-12-18
申请人: Susana Ayesa , Anna Karin Belfrage , Björn Classon , Urszula Grabowska , Ellen Hewitt , Vladimir Ivanov , Daniel Jönsson , Pia Kahnberg , Peter Lind , Magnus Nilsson , Lourdes Odén , Mikael Pelcman , Horst Wähling
发明人: Susana Ayesa , Anna Karin Belfrage , Björn Classon , Urszula Grabowska , Ellen Hewitt , Vladimir Ivanov , Daniel Jönsson , Pia Kahnberg , Peter Lind , Magnus Nilsson , Lourdes Odén , Mikael Pelcman , Horst Wähling
IPC分类号: A61K31/5377 , C07D265/30 , C07D413/12 , C07D307/68 , C07D405/12 , C07C237/52 , C07C311/46 , C07C271/24 , A61K31/415 , A61K31/5375 , A61K31/341 , A61K31/18 , A61K31/166 , A61K31/4965 , A61P25/00 , A61P19/02 , A61P11/06 , A61P9/10 , A61P29/00 , A61P11/00 , A61P17/06 , C07D231/40
CPC分类号: C07C311/21 , C07C237/24 , C07C271/24 , C07C2601/02 , C07C2601/04 , C07C2601/06 , C07C2601/08 , C07D207/34 , C07D213/40 , C07D213/71 , C07D231/14 , C07D231/40 , C07D239/80 , C07D241/24 , C07D277/36 , C07D277/56 , C07D295/215 , C07D307/68 , C07D307/85 , C07D401/12 , C07D403/12 , C07D405/12 , C07D417/12
摘要: Compounds of the formula I whereinR1a is H; and R1b is C1-C6 alkyl, Carbocyclyl or Het; orR1a and R1b together define a saturated cyclic amine with 3-6 ring atoms;R2a and R2b are H, halo, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy; orR2a and R2b together with the carbon atom to which they are attached form a C3-C6cycloalkyl;R3 is a branched C5-C10alkyl chain, C2-C4haloalkyl or C3-C7cycloalkylmethyl,R4 is Het, Carbocyclyl,optionally substituted as defined in the specification and pharmaceutically acceptable salts,hydrates and N-oxides thereof; are inhibitors of cathepsin S and have utility in the treatment of psoriasis, autoimmune disorders and other disorders such as asthma, arteriosclerosis, COPD and chronic pain
摘要翻译: 式Ⅰ化合物,其中R1a是H; 并且R 1b是C 1 -C 6烷基,碳环或Het; 或R 1a和R 1b一起限定具有3-6个环原子的饱和环胺; R2a和R2b是H,卤素,C1-C4烷基,C1-C4卤代烷基,C1-C4烷氧基; 或R 2a和R 2b与它们所连接的碳原子一起形成C 3 -C 6环烷基; R3是支链C 5 -C 10烷基链,C 2 -C 4卤代烷基或C 3 -C 7环烷基甲基,R 4是Het,碳环基,如本说明书中所定义的任选取代,及其药学上可接受的盐,水合物和N-氧化物; 是组织蛋白酶S的抑制剂,并且可用于治疗牛皮癣,自身免疫性疾病和其它疾病如哮喘,动脉硬化,COPD和慢性疼痛